Search

Search Constraints

You searched for: Author/Creator Gamil, M.

Search Results

1. Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection. Issue 6 (6th February 2018)

2. Simeprevir plus sofosbuvir for eight or 12 weeks in treatment‐naïve and treatment‐experienced hepatitis C virus genotype 4 patients with or without cirrhosis. Issue 2 (27th October 2016)